Kenvue Inc. Common Stock vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Direxion Daily FTSE China Bull 3x Shares trades at $25.23 (market cap $560.32M). The key difference: Kenvue Inc. Common Stock is far larger — about 60.8× Direxion Daily FTSE China Bull 3x Shares's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Direxion Daily FTSE China Bull 3x Shares pays none. Which is the better fit depends on your goals.
| KVUE | YINN | |
|---|---|---|
Market Cap | $34.06B | $560.32M |
Volume | 23,267,228 | 1,009,521 |
Sector | Consumer Staples | Leveraged / Inverse |
52-Week High | $19.83 | $52.69 |
52-Week Low | $14.11 | $21.45 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 25 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YINN is trading at $25.27, up 7.26% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The stock lacks disclosed fundamental ratios such as P/E and P/S, and recent news highlights China's economic policies and energy sector dynamics, which may influence its performance. Support is clustered around $23, with resistance at $24.
The outlook remains cautious due to bearish technicals and limited fundamental visibility. Risks include reliance on Chinese economic conditions and potential regulatory changes. Investment opportunities hinge on improved earnings transparency and positive shifts in market sentiment, but current data suggests a neutral to bearish stance for near-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →